Interferon in chronic hepatitis B.

[1]  J. Hoofnagle,et al.  Pilot study of recombinant human α-interferon for chronic type B hepatitis , 1986 .

[2]  A. Dibisceglie,et al.  Recombinant leukocyte interferon treatment of chronic hepatitis B , 1985, Hepatology.

[3]  O. Yokosuka,et al.  Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects. , 1985, Gastroenterology.

[4]  R. Perrillo,et al.  Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B. , 1985, Gastroenterology.

[5]  A. Lok,et al.  Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease. , 1985, Journal of hepatology.

[6]  S. Sherlock,et al.  Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication. , 2008, Liver.

[7]  E. Gelmann,et al.  Hepatitis B virus infection in the acquired immunodeficiency syndrome. , 1984, Annals of internal medicine.

[8]  J. Hoofnagle,et al.  Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. , 1984, Gastroenterology.

[9]  R. Perrillo,et al.  Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis. , 1984, Annals of internal medicine.

[10]  D. Longo,et al.  Acquired Immunodeficiency Syndrome: Epidemiologic, Clinical, Immunologic, and Therapeutic Considerations , 1984 .

[11]  S. Hirschman,et al.  Randomized Controlled Trial of Quinacrine for the Treatment of HBsAg‐Positive Chronic Hepatitis , 2007, Hepatology.

[12]  T. Merigan,et al.  Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection. , 1983, The Journal of infectious diseases.

[13]  Z. Varghese,et al.  Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration. , 1983, The Journal of antimicrobial chemotherapy.

[14]  T. Merigan,et al.  Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection. , 1982, JAMA.

[15]  J. Hoofnagle,et al.  Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. , 1981, Annals of internal medicine.

[16]  T. Merigan,et al.  Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. , 1981, The Journal of infectious diseases.

[17]  W. Weimar,et al.  Differential effects of fibroblast and leucocyte interferon in HBsAg positive chronic active hepatitis , 1979, European journal of clinical investigation.

[18]  J. Oxford,et al.  Trial of ribavirin for the treatment of HBsAg positive chronic liver disease. , 1978, The Journal of antimicrobial chemotherapy.

[19]  T. Merigan,et al.  Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. , 1976, The New England journal of medicine.